Preliminary Results of ERAS Protocol in a Single Surgeon Prospective Case Series.
ERAS
bladder cancer
enhanced recovery after surgery
outcomes
radical cystectomy
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
06 Sep 2022
06 Sep 2022
Historique:
received:
08
07
2022
revised:
18
08
2022
accepted:
01
09
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
28
9
2022
Statut:
epublish
Résumé
Background and Objectives: The aim was to compare the intra and postoperative outcomes between the Enhanced Recovery After Surgery (ERAS) protocol versus the standard of care protocol (SCP) in patients who underwent radical cystectomy performed by a single surgeon. Materials and Methods: A retrospective comparative study was conducted including patients who underwent radical cystectomy from 2017 to 2020. Length of stay (LOS), incidence of ileus, early postoperative complications, and number of re-hospitalizations within 30 days were considered as primary comparative outcomes of the study. Results: Data were collected for 91 patients who underwent cystectomy, and 70 and 21 patients followed the SCP and ERAS protocol, respectively. The mean age of the patients was 70.6 (SD 9.5) years. Although there was a statistically significant difference in time to flatus (TTF) [3 (2.7−3) vs. 1 (1−2 IQR) days, p < 0.001, in the SC hospital and in the ERAS center respectively], no difference was reported in time to first defecation (TTD) [5 (4−6) vs. 4 (3−5.8), p = 0.086 respectively]. The median LOS in the SCP group was 12 (IQR 11−13) days vs. 9 (IQR 8−13 p = 0.024). In the postoperative period, patients reported 22 complications (37% in SCP and 42.8% in ERAS group, p = 0.48). Conclusions: The study reveals how even partial adherence to the ERAS protocols leads to similar outcomes when compared to SCP. As a single surgeon series, our study confirmed the role of surgeons in reducing complications and improving surgical outcomes.
Identifiants
pubmed: 36143911
pii: medicina58091234
doi: 10.3390/medicina58091234
pmc: PMC9501830
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Scand J Urol. 2015;49(4):302-7
pubmed: 25660105
J Int Med Res. 2018 Dec;46(12):5011-5018
pubmed: 30088432
J Urol. 2014 Jul;192(1):50-5
pubmed: 24518775
Med Oncol. 2018 May 9;35(6):95
pubmed: 29744679
BJU Int. 2021 Oct;128(4):440-450
pubmed: 33991045
PLoS One. 2017 Mar 28;12(3):e0174382
pubmed: 28350805
Cancer Treat Res. 2018;175:215-239
pubmed: 30168124
Urology. 2003 Oct;62(4):661-5; discussion 665-6
pubmed: 14550438
Ann R Coll Surg Engl. 2013 Nov;95(8):591-4
pubmed: 24165343
BJU Int. 2008 Mar;101(6):698-701
pubmed: 18190646
Asian J Urol. 2021 Oct;8(4):376-390
pubmed: 34765445
Eur Urol. 2010 Jan;57(1):60-70
pubmed: 19740595
Ann R Coll Surg Engl. 2013 Apr;95(3):200-6
pubmed: 23827292
World J Urol. 2021 Dec;39(12):4363-4371
pubmed: 34196758
Br J Anaesth. 1997 May;78(5):606-17
pubmed: 9175983
Int J Colorectal Dis. 2017 May;32(5):675-681
pubmed: 28285365
Urol Int. 2014;92(1):41-9
pubmed: 23988445
Clin Nutr. 2013 Dec;32(6):879-87
pubmed: 24189391
World J Surg. 2019 Feb;43(2):299-330
pubmed: 30276441
Scand J Urol. 2016;50(1):39-46
pubmed: 26313582
Urol Oncol. 2021 Dec;39(12):835.e9-835.e17
pubmed: 34049782
Eur Urol Focus. 2016 Apr;2(1):19-29
pubmed: 28723446
J Urol. 2015 Nov;194(5):1209-13
pubmed: 26021824
Can Urol Assoc J. 2021 Feb;15(2):33-39
pubmed: 32745002
Obes Surg. 2017 Jan;27(1):226-235
pubmed: 27817086
Eur Urol. 2013 Oct;64(4):588-97
pubmed: 23245816
BJU Int. 2014 Sep;114(3):375-83
pubmed: 24467630
Sci Rep. 2014 Oct 29;4:6820
pubmed: 25352195